Evaluation of patients' preferences for genital herpes treatment

Sexually Transmitted Diseases

Volumn 38, Issue 9, 2011, Pages 802-807

  Scalone, Luciana ^a,b   Watson, Verity ^c   Ryan, Mandy ^c   Kotsopoulos, Nikolaos ^d   Patel, Rajul ^e  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b CHARTA Foundation   (Italy)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d PRMA Consulting   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CLINICAL DECISION MAKING; EPIDEMIC; FEMALE; GENITAL HERPES; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PATIENT PREFERENCE; RECURRENCE RISK; TABLET; VIRUS TRANSMISSION;

ADULT; ANTIVIRAL AGENTS; CHOICE BEHAVIOR; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HERPES GENITALIS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT PREFERENCE; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; RECURRENCE; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 80051787000     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318218702c     Document Type: Article

References (34)

1. Malkin JE. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 2004;11(suppl 1):2A-23A.
2. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 2004;11(suppl 1):24A-35A. (Pubitemid 38529332)
3. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: A global review. J Infect Dis 2002;186(suppl 1):S3-S28. (Pubitemid 35178845)
4. World Health Organization. Available at: http://www.who.int/vaccine- research/diseases/soa-std/en/index.html. Accessed November 2009.
5. Patel R. Progress in meeting today's demands in genital herpes: An overview of current management. J Infect Dis 2002;186(suppl 1):S47-S56. (Pubitemid 35178849)
6. Simmons A. Clinical manifestations and treatment considerations of herpes simplex virus infection. J Infect Dis 2002;186(suppl 1):S71-S77. (Pubitemid 35178852)
7. Tao G, Kassler WJ, Rein DB. Medical care expenditures for genital herpes in the United States. Sex Transm Dis 2000;27:32-38. (Pubitemid 30058902)
8. Szucs TD, Berger K, Fisman DN, et al. The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches. BMC Infect Dis 2001;1:5.
9. Fisman DN, Lipsitch M, Hook EW III, et al. Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States. Sex Transm Dis 2002;29:608-622.
10. Fortenberry JD. The effects of stigma on genital herpes careseeking behaviours. Herpes 2004;11:8-11. (Pubitemid 38529336)
11. Patel R. Educational interventions and the prevention of herpes simplex virus transmission. Herpes 2004;11(suppl 3):155A-160A. (Pubitemid 39145461)
12. Corey L, Wald A, Patel R, et al. Valacyclovir HSV Transmission Study Group. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350:11-20. (Pubitemid 38032179)
13. Patel R, Tyring S, Strand A, et al. Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection. Sex Transm Infect 1999;75:398-402. (Pubitemid 30056236)
14. Corey L. Challenges in genital herpes simplex virus management. J Infect Dis 2002;186(suppl 1):S29-S33. (Pubitemid 35178846)
15. Alexander L, Naisbett B. Patient and physician partnerships in managing genital herpes. J Infect Dis 2002;186(suppl 1):S57-S65. (Pubitemid 35178850)
16. Brentjens MH, Yeung-Yue, Lee SK. Tyring. Recurrent genital herpes treatments and their impact on quality of life. Pharmacoeconomics 2003;21:853-863. (Pubitemid 37056052)
17. Romanowski B, Zdanowic YM, Owens ST. In search of optimal genital herpes management and standard of care (INSIGHTS): Doctors' and patients' perceptions of genital herpes. Sex Transm Infect 2008;84:51-56. (Pubitemid 351195854)
18. Romanowski B, Marina RB, et al; VALTREX HS230017 Study Group. Patients' preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: A randomized study. Sex Transm Dis 2003;30:226-231. (Pubitemid 36297644)
19. Mills J, Mindel AMB. Genital Herpes Simplex infection: Some therapeutic dilemmas. Sex Transm Dis 2003;30:232-233. (Pubitemid 36297645)
20. Patel R. Supporting the patient with genital HSV infection. Herpes 2004;11:87-92. (Pubitemid 40064893)
21. Ryan M, Gerard K, Amaya-Amaya M. Using Discrete Choice Experiments to Value Health and Health Care. Dordrecht, The Netherlands: Springer, 2008.
22. Wordsworth S, Ryan M, Skåtun D, et al. Women's preferences for cervical cancer screening: A study using a discrete choice experiment. Int J Tech Assess Health Care 2006;22:344-350. (Pubitemid 44469441)
23. Watson V, Ryan M, Watson E. Valuing experience factors in the provision of Chlamydia screening: An application to women attending the family planning clinic. Value Health 2009;12:621-623.
24. Brown DS, Johnson FR, Poulos C, et al. Mothers' preference and willingness to pay for vaccinating daughters against human papillomavirus, Vaccine 2010;28:1702-1708.
25. De Bekker-Grob EW, Hofman R, Donkers B, et al. Girls' preference for HPV vaccination: A discrete choice experiment. Vaccine 2010;28:6692-6697.
26. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A metaanalysis. J Infect Dis 2002;185:45-52. (Pubitemid 34043015)
27. Delany-Moretlwe S, Lingappa JR, Celum C. Insights on Interactions between HIV-1 and HSV-2. Curr Infect Dis Rep 2009;11:135-142.
28. Bodsworth NJ, Crooks RJ, Borelli S, et al. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: A randomised, double-blind clinical trial. Genitourin Med 1997;73:110-116. (Pubitemid 27204852)
29. Sacks SL, Aoki FY, Diaz-Mitoma F, et al. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes: A randomized, double-blind multicenter trial. JAMA 1996;276:44-49. (Pubitemid 26231055)
30. Samuelson W, Zeckhauser R. Status quo bias in decision making. J Risk Uncertain 1988;1:7-59.
31. Hundley V, Ryan M. Are women's expectations and preferences for intrapartum care affected by the model-of-care on offer? BJOG 2004;111:550-560. (Pubitemid 38746238)
32. Pitchforth E, Watson V, Tucker J, et al. Models of intrapartum care and women's trade-offs in remote and rural Scotland: A mixed-methods study. Br J Obstet Gynaecol 2008;155:560-569. (Pubitemid 351357565)
33. Lloyd A. The extent of patients' understanding of the risk of treatments. QHC 2001;10(suppl 1):i14-i18.
34. Drake S, Taylor S, Brown D, et al. Regular review: Improving the care of patients with genital herpes. BMJ 2000;321:619-623.